top of page

Biological (Pharmacological) Evaluation of Drugs

Definition

  • Assessing pharmacological activity or toxicological profile using bioassays (in vitro or in vivo).

Examples

  1. Cardiotonic Activity Tests: e.g., Digitalis leaf assay on isolated frog heart.

  2. Antimicrobial Tests: Agar diffusion or dilution methods for detecting antibacterial or antifungal properties.

  3. Toxicity Tests: Acute, subacute, or chronic toxicity studies in animals.

Significance

  • Reflects the true therapeutic or toxic potential of the crude drug.

  • Captures possible synergistic or antagonistic interactions of multiple constituents.

Limitations of Biological Evaluation of Drugs

  • Ethical and regulatory constraints in animal testing.

  • Biological systems can introduce variability in results.


Related Posts

See All
Chemo-Taxonomical Classification

This Chemo-Taxonomical classification is based on the relationship between plant taxonomy and chemical constituents . It helps in...

 
 
 
Physical Evaluation of Drugs

Definition Measurement of physical parameters  and constants that help gauge purity and identity. Common Physical Tests Foreign Matter...

 
 
 
Chemical Evaluation of Drugs

Definition of Chemical Evaluation of Drugs Qualitative  and quantitative chemical analyses to identify and measure active constituents...

 
 
 
bottom of page